Showing results (501-510 of 1,030) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|January 14, 2023
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort studyMatthieu Schmidt, David Hajage, Micha Landoll, et al.
The Lancet. Respiratory Medicine|January 14, 2023
Usual interstitial pneumonia as a stand-alone diagnostic entity: the case for a paradigm shift?Moisés Selman, Annie Pardo, Athol U Wells
The Lancet. Respiratory Medicine|June 1, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Chunlan Zhuang, Kai Chu, et al.
The Lancet. Respiratory Medicine|June 6, 2022
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 studyYuankai Shi, Gongyan Chen, Xiang Wang, et al.
The Lancet. Respiratory Medicine|November 25, 2022
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trialVivienne Kahlmann, Catharina C Moor, Sanne J van Helmondt, et al.
The Lancet. Respiratory Medicine|April 11, 2022
Prevalence of sleep-disordered breathing in an African general population: The Benin Society and Sleep (BeSAS) studyAblo Prudence Wachinou, Corinne Houehanou, Serge Ade, et al.
The Lancet. Respiratory Medicine|October 26, 2013
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialLisa Young, Hye-Seung Lee, Yoshikazu Inoue, et al.
The Lancet. Respiratory Medicine|August 16, 2014
Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trialA A Palmu, J Jokinen, H Nieminen, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Chronic obstructive pulmonary disease and comorbiditiesMarc Decramer, Wim Janssens
The Lancet. Respiratory Medicine|September 7, 2014
Respiratory risks from household air pollution in low and middle income countriesStephen B Gordon, Nigel G Bruce, Jonathan Grigg, et al.
Pageof 103